Navigation Links
Concerted Effort Needed to Fight Drug-Resistant Flu Strain
Date:3/3/2009

Other medications could be effective, while flu shot is best bet, experts say

TUESDAY, March 3 (HealthDay News) -- The global medical community needs to find new solutions to combat the growing resistance to a major flu-fighting drug, an infectious disease expert warns.

"The startling news about oseltamivir [Tamiflu] resistance should unite the global medical and scientific communities in an effort to cope with this rapidly evolving pathogen," wrote Dr. Anne Moscona, author of a perspective piece in the March 5 issue of the New England Journal of Medicine, and a professor of pediatrics and microbiology and immunology at Weill Medical College of Cornell University in New York City.

"For years, we have seen warning signals that highly oseltamivir-resistant influenza viruses could emerge and spread, disabling our defenses against this pathogen. Now the alarm has been sounded, and it is time to act," she added.

The good news is that there are other drugs that work against the flu strain showing resistance to Tamiflu, and your best protection is always the tried-and-true flu shot, experts say.

The resistance to Tamiflu to the H1N1 virus strain was not unexpected, according to Moscona, but the speed of the increase in resistance has been a surprise.

According to an article in this week's issue of the Journal of the American Medical Association, just 12 percent of virus strains last year were resistant to the antiviral drug. This year, that figure has soared to 98 percent. Last year was the first time resistance to Tamiflu was noted at all.

The resistance seems not to be in occurring in response to overuse of the drug, as so often happens with bacteria, but is, instead, "a natural, spontaneously arising variant," Moscona wrote.

Moscona, who has received financial support from pharmaceutical companies Medimmune, GlaxoSmithKline, Roche, Merck, NexBio and Shaklee, pointed to a number of drugs already available or in various phases of research that could be combined in a multi-drug campaign to combat flu resistance.

Some of the candidates are years away. But some, including Relenza (zanamivir), a cousin of Tamiflu, is already available, and another, peramivir, is in Phase 3 trials and close to being released, said Dr. Christine M. Hay, an assistant professor of infectious diseases at the University of Rochester Medical Center.

A multi-drug strategy is likely to be the most effective, Moscona stated, as resistance of virus strains to specific drugs becomes increasingly common.

Current drugs and others in the pipeline should be employed, Moscona wrote. These include:

  • Giving Relenza intravenously. Relenza is a drug in the same class as Tamiflu, but has not yet seen resistance.
  • Peramivir, an experimental neuraminidase inhibitor, is expected to be available intravenously as well as with a shot. Neuraminidase inhibitors are antiviral drugs that block a specific protein on the flu virus.
  • Long-acting inhaled neuraminidase inhibitors, which are, again, not yet licensed, but could be used in one dose as a treatment or once a week for prevention of the flu. "It's not clear how useful this is going to be over what's already there," Hay said. "It's just going to act longer."

The encouraging news about the recent emergence of resistance to Tamiflu, the JAMA article noted, is that the resistant strain of flu is no more virulent than the "normal" strain.

H1N1 is the most common type of flu circulating in the United States. Also, the other two strains appear not resistant, and three other drugs available to fight the flu are still effective.

And as always, the best prevention against the flu is to be vaccinated, health officials emphasized.

"The first thing anybody should do always is to use the vaccine," said John M. Quarles, head and professor of microbial and molecular pathogenesis at Texas A&M Health Science Center College of Medicine. "That's the first line of defense."

More information

Visit the U.S. Centers for Disease Control and Prevention for more on the seasonal flu.



SOURCES: Christine M. Hay, M.D., assistant professor, infectious diseases, University of Rochester Medical Center, New York; John M. Quarles, Ph.D., head and professor, microbial and molecular pathogenesis, Texas A&M Health Science Center College of Medicine, College Station; March 5, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. IOF calls for concerted support for second EU osteoporosis audit
2. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
3. OHSU is part of national effort to preserve, restore fertility in women with cancer
4. New Research From America On the Move Foundation Indicates American Weight Loss Efforts Stalling
5. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
6. PSI Brings its Pioneering Efforts to a Close
7. Disabilities Rising Among Workers; Need for Employer-Driven Disability Awareness, Support Efforts Also Increases
8. Blue Cross Blue Shield of Michigan Launches Effort in Five Michigan Cities with Department of Community Health to Enroll Uninsured Children in MIChild
9. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
10. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
11. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: